undefined
EUTM file information

018690820

Ixactile


April 24, 2022

Trademark Summary

The trademark application Ixactile was filed by Ixaka France, S.A., a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on July 14, 2022, and it was registered by office on October 21, 2022 without any oppositions.

It was designated 'Basic Application' for International Application 1714870 at the World Intellectual Property Organization (WIPO).

The application was filed in English (Spanish was selected as the second language).

A transfer of the trademark registration was recorded on November 7, 2022.


Goods And Services

  • The mark was filed in class 1 with Chemicals for use in science, scientific research and for laboratory use and analytical and diagnostic reagents for in vitro use..
  • The mark was filed in class 5 with following description of goods:
    1. Medicines
    2. Pharmaceutical and veterinary preparations
    3. Chemical, analytical and diagnostic reagents for in vivo use
    4. Chemicals for use in medical research, and medical or veterinary diagnosis
    5. Pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders
    6. Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders
    7. Pharmaceutical preparations for the treatment of metabolic diseases and disorders
    8. Pharmaceutical products for the prevention and treatment of cancer, cardiovascular diseases and genetic disorders
    9. Pharmaceutical and medical preparations and substances
    10. Drug delivery agents
    11. Drug delivery compounds that facilitate the delivery of pharmaceutical products
    12. Drug delivery agents in the form of films that facilitate the delivery of pharmaceutical products
    13. Drug delivery agents in the form of tablet coatings that facilitate the delivery of pharmaceutical products.
  • The mark was filed in class 10 with following description of goods:
    1. Surgical, medical, therapeutic, dental and veterinary apparatus and instruments
    2. Drug delivery devices
    3. Devices used to deliver drugs, drug delivery solutions and suspensions, genes, polymers and biologics to the body
    4. Diagnostic apparatus for medical purposes
    5. Dispensing devices for the prolonged release of active agents
    6. Inhalers for medical purposes
    7. Parts, fittings and accessories for all the aforesaid goods.
  • The mark was filed in class 40 with following description of goods:
    1. Production of cell lines for use in the manufacture of biopharmaceuticals
    2. Protein fabrication, production, and manufacture for others
    3. Custom manufacture of pharmaceuticals
    4. Custom manufacture of biopharmaceuticals
    5. Production of cell lines for use in the manufacture of biopharmaceuticals
    6. Nanoparticles manufacturing.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific, medical and industrial research and development services
    2. Clinical research
    3. Laboratory research
    4. Research and development of new drugs and clinical products
    5. Analysis of materials
    6. Chemical analysis
    7. Laboratory services
    8. Laboratory testing services
    9. Medical laboratory services
    10. Information and advisory services relating to the foregoing, including such services provided on-line from a computer network or the Internet
    11. Research and development services for pharmaceuticals and for the treatment of diseases and injuries
    12. Genetic engineering services
    13. Genetic research
    14. Scientific and technological services and research and development relating thereto
    15. Genetic testing for scientific research purposes
    16. Medical and pharmacological research services
    17. Research and development in the fields of biotechnology, biopharmaceuticals and gene therapy
    18. Clinical trials
    19. Research and development of pharmaceutical preparations
    20. Development of technological platforms services for nanoparticles manufacturing.